430 related articles for article (PubMed ID: 12853792)
21. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
22. Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells.
Steinbach P; Kriegmair M; Baumgartner R; Hofstädter F; Knüchel R
Urology; 1994 Nov; 44(5):676-81. PubMed ID: 7974943
[TBL] [Abstract][Full Text] [Related]
23. Comparison of normal piglet bladder damage after PDT with oral or intravesical administration of ALA.
Van Staveren HJ; Beek JF; Verlaan CW; Edixhoven A; De Reijke TM; Brutel De La RiviERe G; Star WM
Lasers Med Sci; 2002; 17(4):238-45. PubMed ID: 12417977
[TBL] [Abstract][Full Text] [Related]
24. Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum.
van den Akker JT; Iani V; Star WM; Sterenborg HJ; Moan J
Photochem Photobiol; 2000 Nov; 72(5):681-9. PubMed ID: 11107855
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo.
Gerscher S; Connelly JP; Griffiths J; Brown SB; MacRobert AJ; Wong G; Rhodes LE
Photochem Photobiol; 2000 Oct; 72(4):569-74. PubMed ID: 11045731
[TBL] [Abstract][Full Text] [Related]
26. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.
Tyrrell J; Campbell SM; Curnow A
Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):30-8. PubMed ID: 21333932
[TBL] [Abstract][Full Text] [Related]
27. Microscopic localisation of protoporphyrin IX in normal mouse skin after topical application of 5-aminolevulinic acid or methyl 5-aminolevulinate.
de Bruijn HS; Meijers C; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
J Photochem Photobiol B; 2008 Aug; 92(2):91-7. PubMed ID: 18571933
[TBL] [Abstract][Full Text] [Related]
28. Fluorescence cystoscopy following intravesical instillation of 5-aminolevulinic acid: a new procedure with high sensitivity for detection of hardly visible urothelial neoplasias.
Kriegmair M; Stepp H; Steinbach P; Lumper W; Ehsan A; Stepp HG; Rick K; Knüchel R; Baumgartner R; Hofstetter A
Urol Int; 1995; 55(4):190-6. PubMed ID: 8588264
[TBL] [Abstract][Full Text] [Related]
29. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
Loh CS; MacRobert AJ; Bedwell J; Regula J; Krasner N; Bown SG
Br J Cancer; 1993 Jul; 68(1):41-51. PubMed ID: 8318419
[TBL] [Abstract][Full Text] [Related]
30. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma.
Dögnitz N; Salomon D; Zellweger M; Ballini JP; Gabrecht T; Lange N; van den Bergh H; Wagnières G
J Photochem Photobiol B; 2008 Dec; 93(3):140-8. PubMed ID: 18818091
[TBL] [Abstract][Full Text] [Related]
31. Comparison of 5-aminolevulinic acid and its hexylester mediated photodynamic action on human hepatoma cells.
Ren QG; Wu SM; Peng Q; Chen JY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Sep; 34(5):650-4. PubMed ID: 12198571
[TBL] [Abstract][Full Text] [Related]
32. Fluorescence diagnosis of bladder cancer: a novel in vivo approach using 5-aminolevulinic acid (ALA) dendrimers.
François A; Battah S; MacRobert AJ; Bezdetnaya L; Guillemin F; D'Hallewin MA
BJU Int; 2012 Dec; 110(11 Pt C):E1155-62. PubMed ID: 22883132
[TBL] [Abstract][Full Text] [Related]
33. In vivo fluorescence kinetics of porphyrins following intravesical instillation of 5-aminolaevulinic acid in normal and tumour-bearing rat bladders.
Heil P; Stocker S; Sroka R; Baumgartner R
J Photochem Photobiol B; 1997 Apr; 38(2-3):158-63. PubMed ID: 9203377
[TBL] [Abstract][Full Text] [Related]
34. A study of 5-aminolevulinic acid and its methyl ester used in in vitro and in vivo systems of human bladder cancer.
Manivasager V; Heng PW; Hao J; Zheng W; Soo KC; Olivo M
Int J Oncol; 2003 Feb; 22(2):313-8. PubMed ID: 12527928
[TBL] [Abstract][Full Text] [Related]
35. Clearance mechanism of protoporphyrin IX from mouse skin after application of 5-aminolevulinic acid.
Juzeniene A; Iani V; Moan J
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):538-45. PubMed ID: 24284108
[TBL] [Abstract][Full Text] [Related]
36. Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma.
Datta SN; Loh CS; MacRobert AJ; Whatley SD; Matthews PN
Br J Cancer; 1998 Oct; 78(8):1113-8. PubMed ID: 9792160
[TBL] [Abstract][Full Text] [Related]
37. Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin.
Juzeniene A; Juzenas P; Ma LW; Iani V; Moan J
Br J Dermatol; 2006 Oct; 155(4):791-9. PubMed ID: 16965430
[TBL] [Abstract][Full Text] [Related]
38. The effects of protoporphyrin IX-induced photodynamic therapy with and without iron chelation on human squamous carcinoma cells cultured under normoxic, hypoxic and hyperoxic conditions.
Blake E; Allen J; Curnow A
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):575-82. PubMed ID: 24284114
[TBL] [Abstract][Full Text] [Related]
39. Protoporphyrin IX-accumulation in human tumor cells following topical ALA- and h-ALA-application in vivo.
Zenzen V; Zankl H
Cancer Lett; 2003 Dec; 202(1):35-42. PubMed ID: 14643024
[TBL] [Abstract][Full Text] [Related]
40. The effect of photodynamic therapy on rat urinary bladder with orthotopic urothelial carcinoma.
Grönlund-Pakkanen S; Wahlfors J; Talja M; Kosma VM; Pakkanen TM; Ala-Opas M; Alhava E; Moore RB
BJU Int; 2003 Jul; 92(1):125-30. PubMed ID: 12823396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]